Noha A. Mousa

550 total citations
27 papers, 400 citations indexed

About

Noha A. Mousa is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Noha A. Mousa has authored 27 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Noha A. Mousa's work include Ovarian function and disorders (7 papers), Reproductive Biology and Fertility (6 papers) and Endometriosis Research and Treatment (6 papers). Noha A. Mousa is often cited by papers focused on Ovarian function and disorders (7 papers), Reproductive Biology and Fertility (6 papers) and Endometriosis Research and Treatment (6 papers). Noha A. Mousa collaborates with scholars based in Egypt, Canada and United Arab Emirates. Noha A. Mousa's co-authors include Robert F. Casper, Mohamed A. Bedaiwy, Mohamed Abdelgawad, Mais J. Jebrail, Hao Yang, Pavel Metalnikov, Jian Chen, Aaron R. Wheeler, Rachel Forman and Pavel Crystal and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Science Translational Medicine.

In The Last Decade

Noha A. Mousa

23 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noha A. Mousa Egypt 12 160 99 88 63 61 27 400
Mingze Du China 11 130 0.8× 142 1.4× 44 0.5× 23 0.4× 18 0.3× 34 418
Fumitaka Saito Japan 11 83 0.5× 42 0.4× 30 0.3× 85 1.3× 32 0.5× 31 322
Antonella Bonetti Italy 12 49 0.3× 58 0.6× 66 0.8× 3 0.0× 12 0.2× 27 414
Jinfeng Tan China 11 98 0.6× 34 0.3× 2 0.0× 57 0.9× 21 0.3× 31 358
Marjorie Durand France 11 17 0.1× 27 0.3× 63 0.7× 2 0.0× 21 0.3× 31 431
Flavio Andrea Govoni Italy 8 309 1.9× 7 0.1× 15 0.2× 380 6.0× 12 0.2× 20 494
John Wu United States 10 12 0.1× 15 0.2× 25 0.3× 4 0.1× 7 0.1× 26 295
Diana Cassi Italy 11 8 0.1× 9 0.1× 24 0.3× 9 0.1× 67 1.1× 24 361
Elie Akoury Canada 9 4 0.0× 140 1.4× 57 0.6× 17 0.3× 62 1.0× 17 331
Aoife Doyle Australia 11 4 0.0× 50 0.5× 211 2.4× 3 0.0× 9 0.1× 30 557

Countries citing papers authored by Noha A. Mousa

Since Specialization
Citations

This map shows the geographic impact of Noha A. Mousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noha A. Mousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noha A. Mousa more than expected).

Fields of papers citing papers by Noha A. Mousa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noha A. Mousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noha A. Mousa. The network helps show where Noha A. Mousa may publish in the future.

Co-authorship network of co-authors of Noha A. Mousa

This figure shows the co-authorship network connecting the top 25 collaborators of Noha A. Mousa. A scholar is included among the top collaborators of Noha A. Mousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noha A. Mousa. Noha A. Mousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madkour, Mohamed, Nèjia Farhat, Dana N. Abdelrahim, et al.. (2025). Characterizing Genetic, Epigenetic, Nutritional, and Clinico‐Biochemical Profile of Women With Polycystic Ovary Syndrome: A Case–Control Study. Journal of Nutrition and Metabolism. 2025(1). 8817919–8817919.
2.
Mousa, Noha A., et al.. (2024). Potential novel role of the human amniotic membrane as a sustainable hemostat. International Journal of Gynecology & Obstetrics. 167(1). 340–349. 1 indexed citations
3.
Mousa, Noha A., et al.. (2024). Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?. Cancer Medicine. 13(3). e7004–e7004. 2 indexed citations
4.
Badran, Zahi, et al.. (2023). The potential role of the gingival crevicular fluid biomarkers in the prediction of pregnancy complications. Frontiers in Medicine. 10. 1168625–1168625. 5 indexed citations
5.
Honemeyer, Ulrich, et al.. (2022). Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report. Frontiers in Medicine. 9. 870503–870503.
6.
Mousa, Noha A., et al.. (2021). Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling. Frontiers in Endocrinology. 12. 781066–781066. 2 indexed citations
7.
Guraya, Salman Yousuf, et al.. (2021). The impact of an online intervention on the medical, dental and health sciences students about interprofessional education; a quasi-experimental study. BMC Medical Education. 21(1). 457–457. 10 indexed citations
8.
El‐Sayed, Mohamed Y., et al.. (2021). A microfluidic platform for dissociating clinical scale tissue samples into single cells. Biomedical Microdevices. 23(1). 10–10. 8 indexed citations
9.
Mousa, Noha A., et al.. (2019). Monogenic leptin deficiency in early childhood obesity. Pediatric Obesity. 15(1). e12574–e12574. 23 indexed citations
10.
El‐Mokhtar, Mohamed A., et al.. (2018). Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression. The International Journal of Biochemistry & Cell Biology. 105. 84–93. 11 indexed citations
11.
El‐Badri, Nagwa, et al.. (2016). A Cost-Effective Method to Assemble Biomimetic 3D Cell Culture Platforms. PLoS ONE. 11(12). e0167116–e0167116. 22 indexed citations
12.
Mousa, Noha A., Riham Eiada, Pavel Crystal, Dan Nayot, & Robert F. Casper. (2012). The effect of acute aromatase inhibition on breast parenchymal enhancement in magnetic resonance imaging. Menopause The Journal of The North American Menopause Society. 19(4). 420–425. 23 indexed citations
13.
Bedaiwy, Mohamed A., Noha A. Mousa, & Robert F. Casper. (2009). Aromatase Inhibitors: Potential Reproductive Implications. Journal of Minimally Invasive Gynecology. 16(5). 533–539. 7 indexed citations
15.
Mousa, Noha A., Pavel Crystal, Wendy Wolfman, Mohamed A. Bedaiwy, & Robert F. Casper. (2008). Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause The Journal of The North American Menopause Society. 15(5). 875–884. 20 indexed citations
16.
Bedaiwy, Mohamed A., et al.. (2008). Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination. Fertility and Sterility. 91(6). 2501–2507. 14 indexed citations
17.
Bedaiwy, Mohamed A., Noha A. Mousa, & Robert F. Casper. (2008). Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists. Fertility and Sterility. 91(4). 1574–1577. 30 indexed citations
18.
Mousa, Noha A., Mohamed A. Bedaiwy, & Robert F. Casper. (2007). Aromatase Inhibitors in the Treatment of Severe Endometriosis. Obstetrics and Gynecology. 109(6). 1421–1423. 48 indexed citations
19.
Bedaiwy, Mohamed A., Noha A. Mousa, Navid Esfandiari, Rachel Forman, & Robert F. Casper. (2006). Follicular Phase Dynamics with Combined Aromatase Inhibitor and Follicle Stimulating Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism. 92(3). 825–833. 17 indexed citations
20.
Bedaiwy, Mohamed A., et al.. (2006). Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Human Reproduction. 21(11). 2838–2844. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026